Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment
NCT00105417
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
NIH
Sponsor class
Conditions
HIV Infections
HIV
Interventions
DRUG:
IL-7
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)